About GLP-1
GLP-1 (Glucagon-Like Peptide-1) is an incretin hormone peptide involved in glucose homeostasis and widely used in metabolic research. Supplied as a lyophilized powder for laboratory investigations into incretin signaling, insulin secretion pathway markers, and glucagon regulation mechanisms in controlled experimental models. Each batch undergoes analytical verification for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Nail changes with glucagon-like peptide-1 receptor agonists: association, confounding and residual uncertainty. A multinational case-control study.
Recent research on GLP-1: Nail changes with glucagon-like peptide-1 receptor agonists: association, confounding and residual uncertainty. A multinational case-control study.
Read Full Study on PubMedGLP-1 Receptor Agonists and Post-ERCP Outcomes: A Promising Signal That Warrants Cautious Interpretation.
Recent research on GLP-1: GLP-1 Receptor Agonists and Post-ERCP Outcomes: A Promising Signal That Warrants Cautious Interpretation.
Read Full Study on PubMedAdditional Studies
Corrigendum to "The role of GLP-1 and GIP receptor agonists in the treatment of diabetes and obesity" [Pharmacol. Res. 231 (2026) 108365].
Recent research on GLP-1: Corrigendum to "The role of GLP-1 and GIP receptor agonists in the treatment of diabetes and obesity" [Pharmacol. Res. 231 (2026) 108365].
Read on PubMedWhat's Coming Up Next? The Physiology of Gastroparesis and GLP-1 Agonists.
Recent research on GLP-1: What's Coming Up Next? The Physiology of Gastroparesis and GLP-1 Agonists.
Read on PubMedLetter to the Editor. GLP-1 receptor agonists in moyamoya disease: methodological concerns.
Recent research on GLP-1: Letter to the Editor. GLP-1 receptor agonists in moyamoya disease: methodological concerns.
Read on PubMedMetabolic and biochemical predictors of glycemic response after bariatric surgery: a scoping review.
Recent research on GLP-1: Metabolic and biochemical predictors of glycemic response after bariatric surgery: a scoping review.
Read on PubMedCombination of ezetimibe and sericin attenuates cadmium chloride-induced neurotoxicity in an experimental rat model by suppressing oxidative stress and neuroinflammation.
Recent research on GLP-1: Combination of ezetimibe and sericin attenuates cadmium chloride-induced neurotoxicity in an experimental rat model by suppressing oxidative stress and neuroinflammation.
Read on PubMedAssociation of GLP-1 Receptor Agonist Exposure with Platelet Function in Patients with Diabetes and Peripheral Artery Disease After Lower-Extremity Revascularization.
Recent research on GLP-1: Association of GLP-1 Receptor Agonist Exposure with Platelet Function in Patients with Diabetes and Peripheral Artery Disease After Lower-Extremity Revascularization.
Read on PubMedRelated Research
Purchase GLP-1 from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.
